Intrasense is pleased to present the new version 2.8 of its visualization platform with many new features, from clinical applications to improved workflow.

Intrasense announces following a Board meeting on October 8th, 2020, a partial renewal and strengthening of its composition. Michèle Lesieur is coopted as administrator and appointed Chairman of the Board. Anne Larpin is coopted as administrator of the company. The ratification of these cooptations will be submitted to the next ordinary general meeting.

Intrasense announces its 2020 consolidated IFRS half-year results at Group level as of June 30, 2020.

Intrasense announces that the scanner reading protocol dedicated to COVID-19 has obtained its CE marking as a world premiere.

Intrasense continues its involvement in the fight against COVID-19 and announces the availability on Friday April 17th, 2020 of a second version of its scanner reading protocol dedicated to the epidemic.

Intrasense combines its technological expertise with the clinical expertise of the Compagnie de Télémédecine (CTM Groupe) by deploying to all of the group's radiotherapy specialists the new scanner reading protocol dedicated to COVID-19.

The company announces the release and immediate availability of a specific scanner reading protocol dedicated to COVID-19.

Intrasense™ announces its 2019 annual results.

Artificial intelligence will be highlighted on Intrasense™ booth (#6956). The new version of Myrian® platform enabling artificial intelligence to truly be embedded into the daily workflow and clinical routine.

All innovations will be presented at JFR 2019 on the Intrasense ™ booth (# 213A). The new version of Myrian® as well as the XP-Mammo application will be display.